中华内分泌代谢杂志
中華內分泌代謝雜誌
중화내분비대사잡지
CHINESE JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2008年
3期
322-323
,共2页
顾丽萍%吴艺捷%王煜非%施念玮%董维平
顧麗萍%吳藝捷%王煜非%施唸瑋%董維平
고려평%오예첩%왕욱비%시념위%동유평
已酮可可碱%糖尿病%1型%小鼠%近交NOD%Fas%FasL
已酮可可堿%糖尿病%1型%小鼠%近交NOD%Fas%FasL
이동가가감%당뇨병%1형%소서%근교NOD%Fas%FasL
Pentoxifylline%Diabetes mellitus%type l%Mice%inbred NOD%Fas%FasL
环磷酰胺加速NOD小鼠发病,腹腔注射己酮可可碱(pentoxifylline, PTX)后监测糖尿病发病率, 检测胰岛细胞凋亡、胰岛素表达以及胰腺、脾脏Fas和FasL mRNA的表达.结果 提示PTX组糖尿病发病率下降(P<0.05),胰岛细胞凋亡减少,而胰岛细胞胰岛素的表达增加,胰腺FasL mRNA的表达下降(P<0.05),Fas有下降趋势但差异无统计学意义,脾脏Fas和FasL mRNA表达明显增强(P<0.05或P<0.01).
環燐酰胺加速NOD小鼠髮病,腹腔註射己酮可可堿(pentoxifylline, PTX)後鑑測糖尿病髮病率, 檢測胰島細胞凋亡、胰島素錶達以及胰腺、脾髒Fas和FasL mRNA的錶達.結果 提示PTX組糖尿病髮病率下降(P<0.05),胰島細胞凋亡減少,而胰島細胞胰島素的錶達增加,胰腺FasL mRNA的錶達下降(P<0.05),Fas有下降趨勢但差異無統計學意義,脾髒Fas和FasL mRNA錶達明顯增彊(P<0.05或P<0.01).
배린선알가속NOD소서발병,복강주사기동가가감(pentoxifylline, PTX)후감측당뇨병발병솔, 검측이도세포조망、이도소표체이급이선、비장Fas화FasL mRNA적표체.결과 제시PTX조당뇨병발병솔하강(P<0.05),이도세포조망감소,이이도세포이도소적표체증가,이선FasL mRNA적표체하강(P<0.05),Fas유하강추세단차이무통계학의의,비장Fas화FasL mRNA표체명현증강(P<0.05혹P<0.01).
NOD mice were treated with pentoxifylline (FTX) to investigate the incidence of cyclophosphamide-accelerated diabetes, the apoptosis and the insulin expression of β-cells and expressions of Fas or FasL mRNA in both pancreas and spleen. The results showed that incidence of diabetes in PTX group was significantly lower compared with control group (P<0.05). The apoptosis of β-cells was decreased in PTX group with higher insulin expression level in islet cells. The expression of FasL mRNA in pancreas of PTX group was lower than that of control group (P<0.05), and there was no significant difference in Fas mRNA expression between two groups. Both Fas and FasL mRNA levels in spleen of PTX group were much higher than those of control group (P<0.05 or P<0.01).